NIMBUS

Details for Australian Trade Mark No. 1386080 (hide)

Owner Celgene Corporation

Convention US 17 August 2010 85109283

Filing Date 25 August 2010

Classes

Class 42 Medical and scientific research, including conducting clinical trials; conducting clinical trials on the safety and effectiveness of pomalidomide; medical and scientific research, namely, conducting clinical trials on the safety and effectiveness of a drug for multiple myeloma

Event Publications

21 October 2010 Application filed

16 December 2010 Application Accepted

7 April 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1386081-OBIVET

1386079-ESTEEM